1BMRN fundamentals
An in-depth look to BIOMARIN PHARMACEUTICAL operating, investing, and financing activities
1BMRN free cash flow for Q3 24 is 182.34 M EUR. For 2023, 1BMRN free cash flow was 56.69 M EUR and operating cash flow was 144.29 M EUR.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM